Connection
Michail Mavros to Vancomycin
This is a "connection" page, showing publications Michail Mavros has written about Vancomycin.
|
|
Connection Strength |
|
|
|
|
|
0.515 |
|
|
|
-
Mavros MN, Tansarli GS, Vardakas KZ, Rafailidis PI, Karageorgopoulos DE, Falagas ME. Impact of vancomycin minimum inhibitory concentration on clinical outcomes of patients with vancomycin-susceptible Staphylococcus aureus infections: a meta-analysis and meta-regression. Int J Antimicrob Agents. 2012 Dec; 40(6):496-509.
Score: 0.415
-
Vardakas KZ, Mavros MN, Roussos N, Falagas ME. Meta-analysis of randomized controlled trials of vancomycin for the treatment of patients with gram-positive infections: focus on the study design. Mayo Clin Proc. 2012 Apr; 87(4):349-63.
Score: 0.100